Why the study?
Does conditional cardiac-specific overexpression of FKBP12.6 prevent triggered ventricular tachycardia in a mouse model under stress conditions?
Population
Mouse model (n=37 for VT induction; 23 control, 14 transgenic) and isolated cardiac myocytes
Comparison
Conditional cardiac-specific overexpression of… vs Control mice
Design
Preclinical
Authors
Loading...
Supports FKBP12.6-RyR2 stabilization for stress-triggered VT prevention; hypothesis-generating from mouse data alone.
Does conditional cardiac-specific overexpression of FKBP12.6 prevent triggered ventricular tachycardia in a mouse model under stress conditions?
Increased FKBP12.6 binding to RyR2 prevents triggered ventricular tachycardia in a mouse model under stress conditions, highlighting the FKBP12.6-RyR2 complex as a potential pharmacological target for VT prevention.
Gellen et al. (2008) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: